Interleukin-8 modulates growth and invasiveness of estrogen receptor-negative breast cancer cells.
about
The histone H2B-specific ubiquitin ligase RNF20/hBRE1 acts as a putative tumor suppressor through selective regulation of gene expressionWound healing and cancer stem cells: inflammation as a driver of treatment resistance in breast cancerThe CXCL8-CXCR1/2 pathways in cancerSTAT3 can be activated through paracrine signaling in breast epithelial cells.Selective gene-expression profiling of migratory tumor cells in vivo predicts clinical outcome in breast cancer patients.ERalpha-negative and triple negative breast cancer: molecular features and potential therapeutic approachesTherapeutic CK2 inhibition attenuates diverse prosurvival signaling cascades and decreases cell viability in human breast cancer cells.Increased NOS2 predicts poor survival in estrogen receptor-negative breast cancer patients.Targeting IL-8 in colorectal cancer.BLT2 up-regulates interleukin-8 production and promotes the invasiveness of breast cancer cellsDysfunctional activation of neurotensin/IL-8 pathway in hepatocellular carcinoma is associated with increased inflammatory response in microenvironment, more epithelial mesenchymal transition in cancer and worse prognosis in patientsCandidate pathways linking inducible nitric oxide synthase to a basal-like transcription pattern and tumor progression in human breast cancer.Interleukin-8 promotes canine hemangiosarcoma growth by regulating the tumor microenvironment.miR-520b regulates migration of breast cancer cells by targeting hepatitis B X-interacting protein and interleukin-8Expression of the inflammatory chemokines CCL2, CCL5 and CXCL2 and the receptors CCR1-3 and CXCR2 in T lymphocytes from mammary tumor-bearing mice.The functional role of reactive stroma in benign prostatic hyperplasia.Breast cancer stem cells, cytokine networks, and the tumor microenvironment.The role of adipose-derived stem cells in breast cancer progression and metastasis.Screening of feature genes in distinguishing different types of breast cancer using support vector machine.Extravillous trophoblast and decidual natural killer cells: a remodelling partnership.Chemical and physical properties of carbonated hydroxyapatite affect breast cancer cell behavior.PGE2 induces interleukin-8 derepression in human astrocytoma through coordinated DNA demethylation and histone hyperacetylation.EGFRvIII promotes glioma angiogenesis and growth through the NF-κB, interleukin-8 pathwayProstaglandin F2alpha-F-prostanoid receptor signaling promotes neutrophil chemotaxis via chemokine (C-X-C motif) ligand 1 in endometrial adenocarcinomaCXCR4 and matrix metalloproteinase-1 are elevated in breast carcinoma-associated fibroblasts and in normal mammary fibroblasts exposed to factors secreted by breast cancer cells.Tumor angiogenesis: MMP-mediated induction of intravasation- and metastasis-sustaining neovasculature.Sohlh2 suppresses epithelial to mesenchymal transition in breast cancer via downregulation of IL-8.EpCAM modulates NF-κB signaling and interleukin-8 expression in breast cancer.Recent advances reveal IL-8 signaling as a potential key to targeting breast cancer stem cells.Adipose-derived Mesenchymal Stem Cells (ASCs) may favour breast cancer recurrence via HGF/c-Met signaling.Human adipose stem cell differentiation is highly affected by cancer cells both in vitro and in vivo: implication for autologous fat grafting.The Tumor-Promoting Flow of Cells Into, Within and Out of the Tumor Site: Regulation by the Inflammatory Axis of TNFα and Chemokines.Targeting CSCs within the tumor microenvironment for cancer therapy: a potential role of mesenchymal stem cells.Dynamic regulation of cancer stem cells and clinical challenges.Human plasmacytoid dendritic cells: from molecules to intercellular communication networkNeutrophils: important contributors to tumor progression and metastasis.Emerging strategies for cancer immunoprevention.Interleukin-8 is a key mediator of FKBP51-induced melanoma growth, angiogenesis and metastasisZerumbone suppresses IL-1β-induced cell migration and invasion by inhibiting IL-8 and MMP-3 expression in human triple-negative breast cancer cells.Cytokines in osteoblast-conditioned medium promote the migration of breast cancer cells.
P2860
Q24318500-A9DA6B7E-0A83-4BC2-B34A-BD2B325912C8Q27023599-22766FCF-1F54-4054-83A6-76ED1DC030A6Q28075994-3C034D2B-380D-414C-AF94-C9CE178648F9Q30849602-195876BF-FE2A-4671-816C-0529CE7E0F58Q33739307-338F6FEA-47DF-43BC-AB1E-35413343BF68Q34119028-1F210C83-72E9-4E2A-BF42-9D09898A0FEFQ34227776-39A36C9D-2A53-4BEB-8A2C-6BBAC844546CQ34245323-8A99CA54-8C96-4B9F-BB73-925A950CDD40Q34267408-06AC6704-5F5E-41B6-877F-95A4564AF91DQ34474210-B3E2F720-C6C7-4476-AAE1-A7980882D789Q34589814-2D418B34-79B1-4897-897E-C44F9F077DCEQ34593813-CDBCC27E-D5A4-44DE-82AA-5056906919CFQ34633575-CA27E5FC-C50B-4E5B-BA73-52E88C786C16Q34787462-01FB0D27-40D4-44C9-8737-24A79927E9DDQ35166851-802F119B-A514-4CF8-ABF9-D7BFA5C30131Q35231687-121E05CA-F0E2-449B-812B-BEB625BC63E3Q35571904-BC104812-FC6F-4CB8-9747-EE8A58741E30Q35592378-98166C15-3059-44E3-8569-9252F552CB60Q36015125-DDD578EC-9121-4C16-9E37-51B4FD561953Q36026812-9C2851DC-04AA-43CE-B03D-950A61DB9D8BQ36029627-372DF27B-75FE-4BE8-8BA8-E082CEF8FB8DQ36402780-0BEB0A76-F3E3-4D39-97E7-6CB21ACED988Q36510801-254A3394-6EC8-42C6-9AC0-E5DF02908D98Q37266333-DF6FF7BA-7C51-48E1-96C3-3F11558E820AQ37344836-2209743E-F00A-4771-8C40-F84E33A74C48Q37364878-4B143A9B-5935-425F-9048-67372BE0349DQ37580242-A9ACCAA7-E482-46F0-814A-F0025F1FC02BQ37650603-E02CA006-56FE-4DCF-A7D7-2618DDDF2540Q37690257-0E5EFB2F-A880-4348-B5D1-AC67C1ED0039Q37718453-5EE1E6EC-61CE-426E-80FC-5686F575A675Q37744842-90FAAC24-87E6-40F0-8E59-FEA2653B75FAQ37970636-3B717E2B-D08F-428A-ADAD-D845ADA9C4E9Q38033243-3364758E-C880-41BF-8C84-6A6291DEE8F6Q38038526-07849E7C-4123-4E2C-851D-01DFE4805657Q38166716-8860C4B2-1C21-4968-8C35-4ECA4A20C85EQ38585102-906D4162-BC56-4659-B515-192E9B345D60Q38585850-FDD43135-0B9C-48CC-8E49-6573F7018421Q38878910-2BB0797E-83E4-48F6-973C-63AF79DA0215Q38988976-DAE874A8-F96D-4473-A917-8E186D1F5865Q39096935-C17D3854-110B-49BE-A5FF-D3297C25E655
P2860
Interleukin-8 modulates growth and invasiveness of estrogen receptor-negative breast cancer cells.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Interleukin-8 modulates growth ...... -negative breast cancer cells.
@en
type
label
Interleukin-8 modulates growth ...... -negative breast cancer cells.
@en
prefLabel
Interleukin-8 modulates growth ...... -negative breast cancer cells.
@en
P2093
P356
P1476
Interleukin-8 modulates growth ...... -negative breast cancer cells.
@en
P2093
Cai-Sheng Ye
Mei-Sze Chua
Shen-Ming Wang
Yi-Fan Zhu
P2860
P304
P356
10.1002/IJC.22930
P577
2007-11-01T00:00:00Z